Cas no 1788041-50-8 (endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride)
endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- (1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride
- endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride
- (1R,5S,6S)-REL-8-AZABICYCLO[3.2.1]OCTAN-6-OL HCL
- 1788041-50-8
- D73157
- P15059
- rel-(1R,5S,6S)-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride
- CS-0059072
- (1R,5S,6S)-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride
- (1R,5S,6S)-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride
- PS-17388
- (1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-olhydrochloride
-
- MDL: MFCD28502523
- Inchi: 1S/C7H13NO.ClH/c9-7-4-5-2-1-3-6(7)8-5;/h5-9H,1-4H2;1H/t5-,6+,7+;/m1./s1
- InChI Key: JBKIAGJIMKQZEP-NLRFIBDTSA-N
- SMILES: Cl.O[C@H]1C[C@H]2CCC[C@@H]1N2
Computed Properties
- Exact Mass: 163.0763918Da
- Monoisotopic Mass: 163.0763918Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 115
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 3
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 32.3?2
endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| ChemScence | CS-0053595-100mg |
(1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 100mg |
$252.0 | 2022-04-27 | ||
| ChemScence | CS-0053595-250mg |
(1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 250mg |
$420.0 | 2022-04-27 | ||
| ChemScence | CS-0053595-1g |
(1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 1g |
$1125.0 | 2022-04-27 | ||
| eNovation Chemicals LLC | D499078-100mg |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 100mg |
$235 | 2024-07-21 | |
| eNovation Chemicals LLC | D499078-250MG |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 250mg |
$360 | 2024-07-21 | |
| eNovation Chemicals LLC | D499078-500MG |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 500mg |
$600 | 2024-07-21 | |
| eNovation Chemicals LLC | D499078-1G |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 1g |
$900 | 2024-07-21 | |
| eNovation Chemicals LLC | D499078-5G |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 5g |
$2705 | 2024-07-21 | |
| eNovation Chemicals LLC | D499078-10G |
(1R,5S,6S)-rel-8-azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 97% | 10g |
$4510 | 2024-07-21 | |
| Chemenu | CM294337-1g |
(1R,5S,6S)-rel-8-Azabicyclo[3.2.1]octan-6-ol hydrochloride |
1788041-50-8 | 95% | 1g |
$*** | 2023-03-30 |
endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride Related Literature
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
-
2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
Additional information on endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride
Comprehensive Overview of endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride (CAS No. 1788041-50-8): Structure, Applications, and Research Insights
The compound endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride (CAS No. 1788041-50-8) is a bicyclic organic molecule featuring a unique azabicyclo scaffold, which has garnered significant interest in pharmaceutical and chemical research. Its structural complexity, characterized by a fused 8-azabicyclo[3.2.1]octane core and a hydroxyl group at the 6-position, makes it a valuable intermediate for drug discovery. The hydrochloride salt form enhances its solubility and stability, broadening its utility in synthetic applications.
Recent trends in drug development highlight the growing demand for nitrogen-containing heterocycles, with endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride emerging as a key candidate. Researchers are particularly intrigued by its potential as a building block for central nervous system (CNS) therapeutics, given the structural resemblance to tropane alkaloids. This aligns with the surge in searches for "novel CNS drug scaffolds 2024" and "azabicyclic compounds in medicine," reflecting its relevance in cutting-edge science.
From a synthetic chemistry perspective, the bicyclo[3.2.1]octane framework offers stereochemical rigidity, enabling precise spatial control in molecular design. This property is critical for structure-activity relationship (SAR) studies, a frequently searched topic among medicinal chemists. The compound’s hydrochloride salt form also addresses common formulation challenges, such as bioavailability—a hot topic in forums discussing "API salt selection strategies."
Beyond pharmaceuticals, CAS 1788041-50-8 has applications in material science, where its rigid structure contributes to the development of chiral catalysts and ligands for asymmetric synthesis. This dual utility resonates with queries like "multifunctional heterocycles in catalysis," underscoring its interdisciplinary appeal. Analytical techniques such as NMR, HPLC, and X-ray crystallography are typically employed to characterize its purity and conformation, ensuring reproducibility—a priority for researchers searching "QC protocols for bicyclic compounds."
In conclusion, endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride represents a versatile scaffold with untapped potential. Its alignment with trending search terms like "next-gen drug intermediates" and "sustainable synthesis of azabicycles" positions it as a compound of enduring scientific and industrial significance. Future studies may explore its role in green chemistry initiatives or bioconjugation techniques, further expanding its impact.
1788041-50-8 (endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride) Related Products
- 529484-13-7(3,4-PYRROLIDINEDIOL, 2-METHYL-, HYDROCHLORIDE, (2S,3S,4R)-)
- 946434-18-0(8-Azabicyclo[3.2.1]octan-6-ol)
- 478922-47-3((3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol Hydrochloride)
- 107633-95-4(8-Azabicyclo[3.2.1]octane-2,7-diol,(1R,2S,5S,7S)-)
- 107259-50-7(Baogongteng C)
- 455325-03-8(8-Azabicyclo[3.2.1]octane-2,3,6-triol, (1S,2R,3R,5S,6R)- (9CI))
- 98900-30-2((2R,3S)-2-(hydroxymethyl)pyrrolidin-3-ol;hydrochloride)
- 1788054-92-1(exo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride)
- 1369774-30-0((1R,5S,6R)-rel-8-Azabicyclo[3.2.1]octan-6-ol)
- 1009335-36-7((3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol;hydrochloride)